poisar

Stocks · News reference

Photocure Partners with Clinigen to Expand Access to Hexvix/Cysview

Fiscal.ai

Photocure has entered into a partnership with Clinigen to launch a Named Patient Program, aiming to broaden access to its bladder cancer diagnostic drug, Hexvix/Cysview.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
fiscal.ai
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. Zacks Investment ResearchNa

    Is Invesco Global Water ETF (PIO) a Strong ETF Right Now?

    The Invesco Global Water ETF (PIO) is a smart beta ETF tracking water-related companies globally with $269.1 million in assets. However, its 0.75% expense ratio is relatively high compared to alternatives like First Trust Water ETF (FIW) at 0.50% and Invesco Water Resources ETF (PHO) at 0.59%. PIO's year-to-date performance is modest at 1.81%, with a medium risk profile and top holdings including Pentair, Ferguson Enterprises, and Ecolab.